Related Experiment Video
Updated: Jul 7, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Reducing the hospitalization epidemic of chronic heart failure by disease management programs
Anna Belfiore1, Rosa Stranieri2, Maria Elena Novielli2
1Clinica Medica "A. Murri" & Division Internal Medicine, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University "Aldo Moro" Medical School, Bari, Italy. belfiore.murri@gmail.com.
Insights
Heart failure management programs enhance patient care and reduce hospitalizations. A holistic, patient-centered approach, including telemonitoring, is crucial for lifelong management of heart failure (HF) patients.
Area of Science:
- Cardiology
- Public Health
- Geriatrics
Background:
- Chronic heart failure (HF) is a leading cause of hospitalization in Europe, with increasing rates due to population aging.
- Hospitalization signifies a critical juncture in HF, elevating risks of re-hospitalization and mortality.
- Effective management programs are essential to improve care quality and mitigate the hospitalization burden for HF patients.
Purpose of the Study:
- To highlight the benefits of heart failure management programs in optimizing patient care and reducing hospitalizations.
- To emphasize the importance of a patient-centered approach and emerging technologies like telemonitoring.
- To advocate for lifelong, differentiated follow-up strategies for all heart failure patients.
Main Methods:
- Review of evidence from randomized clinical trials and multidisciplinary programs.
- Analysis of the components of effective HF management: drug optimization, patient education, early decompensation recognition, and comorbidity management.
- Evaluation of different care settings, including community HF clinics, hospital outpatient clinics, and home-based care through telemonitoring.
Main Results:
- HF management programs improve treatment adherence and reduce unplanned hospital readmissions.
- Multidisciplinary programs and home-visiting demonstrate significant reductions in HF and all-cause hospitalizations and mortality.
- Telemonitoring offers continuous home-based care, enhancing continuity for HF patients.
Conclusions:
- A holistic, patient-centered approach is vital for optimizing HF care, considering individual patient needs.
- Differentiated, lifelong follow-up strategies are recommended for all HF patients, tailored to their specific requirements.
- Integrating community clinics, hospital outpatient services, and telemonitoring can create a comprehensive system of care for heart failure.
Abstract:
Chronic heart failure is the most common cause of hospitalization in Europe and rates are steadily increasing due to aging of the population. Hospitalization identifies a fundamental change in the natural history of heart failure (HF) increasing the risk of re-hospitalization and mortality. Heart failure management programs improve the quality of care for HF patients and reduce hospitalization burden. The goals of the heart failure management programs include optimization of drug therapy, patient education, early recognition of signs of decompensation, and management of comorbidities. Randomized clinical trials evidenced that system of care for heart failure patients improved adherence to treatment and reduced unplanned re-admissions to hospital. Multidisciplinary programs and home-visiting have shown improved efficacy with reductions in HF and all-cause hospitalizations and mortality. Community HF clinics should take care of the management of stable patients in strict contact with primary care, while hospital out-patients clinics should care of patients with severe disease or persistent clinical instability, candidates to advanced treatment options. In any case a holistic, patient-centered approach is suggested, to optimize care considering the needs of the individual patient. Telemonitoring is a new opportunity for HF patients, because it allows the continuity of care at home. All heart failure patients should require follow-up in a specific management program, but most of date come from clinical trials that included high-risk patients. While clinical trials have a specified duration (from months to some years), lifelong follow-up is recommended with differentiated approaches according to the patient's need.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Pathophysiology of Heart Failure
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Heart Failure Drugs: β-Blockers
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

